A 52-year-old man with a 10-year history of hypertension presents to the outpatient clinic. He has been on amlodipine 5 mg daily for the past 3 years with reasonable blood pressure control (BP 138/88 mmHg). However, over the last 2 months, he has developed persistent bilateral ankle swelling and gum hyperplasia. His renal function and electrolytes are normal. He denies any new medications or dietary changes. What is the most appropriate next step in his management?

Explanation

## Clinical Scenario Analysis The patient presents with two classic adverse effects of calcium channel blockers (CCBs), specifically amlodipine: 1. **Peripheral edema** — dose-dependent, occurs in 5–10% of patients 2. **Gingival hyperplasia** — idiosyncratic, seen in ~10% of CCB users ### Why These Are CCB-Related **Key Point:** Both peripheral edema and gingival hyperplasia are well-recognized, drug-specific side effects of dihydropyridine CCBs like amlodipine. They are NOT dose-dependent (in the case of gingival hyperplasia) and do NOT resolve by adding other agents. **Clinical Pearl:** Gingival hyperplasia with CCBs is thought to result from altered collagen metabolism and increased growth factor activity in gingival fibroblasts. It is NOT reversible while the drug is continued. ### Management Strategy Since both adverse effects are attributable to amlodipine and the patient's BP is reasonably controlled, the best approach is to **switch to a different class of antihypertensive** rather than add more drugs or increase the dose. ### Why ACE Inhibitor Is the Best Choice | Feature | ACE Inhibitor | Beta-Blocker | Diuretic | |---------|---------------|--------------|----------| | Efficacy in hypertension | Excellent | Excellent | Good | | Renal protection | Yes (especially in CKD) | No | Can worsen glucose control | | Peripheral edema risk | No | No | No | | Gingival hyperplasia risk | No | No | No | | Additional benefit | Reduces proteinuria | Reduces HR/cardiac workload | Can cause hypokalemia | **High-Yield:** ACE inhibitors are preferred as second-line agents in hypertension and offer additional cardioprotection, particularly in patients with diabetes or chronic kidney disease. They do NOT cause the edema or gingival hyperplasia seen with CCBs. ### Why Not Beta-Blockers? While beta-blockers are effective antihypertensives, they: - Lack the additional renal protective benefits of ACE inhibitors - May worsen glucose metabolism (relevant for long-term use) - Do not address the underlying CCB-induced side effects as elegantly as ACE inhibitors ### Why Not Continue Amlodipine + Add Diuretic? Adding a diuretic does NOT address the gingival hyperplasia, which is a direct drug effect. The edema may improve, but the patient will continue to suffer gingival hyperplasia, which can lead to poor oral hygiene, periodontal disease, and tooth loss.